Rapid Micro Biosystems (RPID) Amortizatization of Intangibles (2020 - 2022)

Rapid Micro Biosystems (RPID) reported Amortizatization of Intangibles of $28000.0 for Q2 2022, up 566.67% sequentially from -$6000.0 in Q1 2022.

Rapid Micro Biosystems (RPID) Amortizatization of Intangibles (2020 - 2022) Analysis & Trends

Rapid Micro Biosystems (RPID) has 3 years of Amortizatization of Intangibles data on file, last reported at $28000.0 in Q2 2022.

For the quarter ending Q2 2022, Amortizatization of Intangibles changed N/A year-over-year to $28000.0; the trailing twelve-month figure through Jun 2022 stood at $21000.0 (changed N/A YoY), and the FY2021 full-year result was $3000.0, changed N/A from the prior year.
Amortizatization of Intangibles advanced to $28000.0 in Q2 2022, from -$6000.0 in the prior quarter.
In the past five years, Amortizatization of Intangibles ranged from a high of $28000.0 in Q2 2022 to a low of -$6000.0 in Q1 2022.
A 3-year average of $8750.0 and a median of $6500.0 in 2020 frame the typical range for Amortizatization of Intangibles.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Amortizatization of Intangibles (Qtr)
1	Abbott Laboratories	182.32 Bn	175.02 Bn	6.27 Bn	-
2	Stryker	128.75 Bn	125.88 Bn	3.81 Bn	-
3	Medtronic	107.83 Bn	98.61 Bn	6.41 Bn	-
4	Boston Scientific	67.61 Bn	66.15 Bn	3.61 Bn	-
5	Edwards Lifesciences	48.13 Bn	44.45 Bn	1.29 Bn	-
6	Dexcom	28.26 Bn	27.14 Bn	750.30 Mn	-
7	GE HealthCare Technologies	27.78 Bn	25.50 Bn	1.98 Bn	-
8	Smith & Nephew	26.99 Bn	26.41 Bn	-	-
9	Koninklijke Philips	23.92 Bn	20.80 Bn	2.07 Bn	-
10	Rapid Micro Biosystems	89.73 Mn	80.30 Mn	371,000.00	-

Download Data